Condition: Parkinson's Disease Psychosis · Dementia With Lewy Bodies · Sponsor: The University of Texas Health Science Center at San Antonio
The primary objective of this study is to determine whether treatment with pimavanserin or quetiapine is associated with a greater improvement in psychosis when used in a routine clinical setting to treat hallucinations and/or delusions due to Parkinson's disease (PD) or dementia with Lewy bodies (DLB) - collectively referred to as Lewy body disease (LBD).
This description comes directly from the study's public registry record.
Carolyn Paiz, BS · 210-450-8830 · paizc@uthscsa.edu
Always discuss trial participation with your own doctor first.
| University Health System | San Antonio, Texas, United States | Recruiting |
| UT Health Science Center - San Antonio | San Antonio, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05590637